Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ADAC predicts downturn after strong second quarter

This article was originally published in Clinica

Executive Summary

Nuclear medicine company ADAC Laboratories has reported strong revenue growth in its second quarter, but predicts a sharp drop for the third quarter as the effects of more stringent revenue recognition policies are felt. ADAC is continuing to search for a new CFO, after the interim appointment of Robert Bunje to replace Andre Simone (see Clinica No 860, p 11).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel